Open Access 01-12-2020 | Letter
The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial
Published in: Trials | Issue 1/2020
Login to get access